WINTERTHUR, Schweiz–(BUSINESS WIRE)–betterview, ein Anbieter für refraktive Chirurgie in der Schweiz, gibt bekannt, dass das Unternehmen die Marke von 20’000 behandelten Augen erreicht hat. Der Meilenstein wurde seit der Gründung des Unternehmens im …
Category: News
Veligrotug Shows Promise for Treating Thyroid Eye Disease
The THRIVE and THRIVE-2 clinical trials showed significant improvements in proptosis and diplopia in active as well as chronic thyroid eye disease, earning FDA Breakthrough Therapy designation. Medscape Medical News
Can Medicare Afford the Perpetual Human?
As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer and healthier life. Medscape Medical News
Continuous Use of Tear Drops Eases Dry Eye Symptoms in AMD
Continuous use of eye drops in patients with neovascular AMD who receive frequent eye injections soothes dry eye more effectively than intermittent use, a new study shows. Medscape Medical News
NIH Launches Agency-Wide Plan for Autoimmune Research
The 5-year strategy aims to accelerate diagnosis, prevention, and treatment for the millions living with autoimmune diseases in the US. Medscape Medical News
Experts Warn of Hidden Psychological Burden in Glaucoma
Anxiety and depression are more common among people with glaucoma than in the general population but often go unrecognized, highlighting the need for routine psychometric screening in this population, a new study finds. Medscape Medical News
Identifying, Referring Cataracts in Primary Care
Cataracts can happen at any age, but risk is heightened in older adults and people with diabetes. Medscape Medical News
Affirm et Groupe Vision New Look s’associent pour offrir des options de paiement flexibles dans les principales lunetteries au Canada
TORONTO–(BUSINESS WIRE)–Affirm (NASDAQ : AFRM), le réseau de paiement qui aide les consommateurs à acheter ce qu’ils souhaitenten toute liberté et soutient la croissance des marchands, et Groupe Vision New Look, un chef de file nord-américain des mag…
Affirm and New Look Vision Group partner to offer flexible payment options across leading eyewear retailers in Canada
TORONTO–(BUSINESS WIRE)–Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, and New Look Vision Group, a leading North American optical retailer with over 475 stores in the US and Canada, today announc…
Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 with Regeneron Pharmaceuticals, F. Hoffmann-La Roche, and Bayer Leading Innovations – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Myopic Macular Degeneration Market – A Global and Regional Analysis: Focus on Regional and Country Analysis – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global myopic …
Sleep Apnea Can Raise Risk for Retinal Vein Disease
A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is associated with worse outcomes in patients who already have the condition. Medscape Medical News
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
IRVINE, Calif.–(BUSINESS WIRE)– #clinicaltrials–Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evalu…
Study Finds Link Between IL-6 and Diabetic Eye Disease
A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be predictive of disease progression. Medscape Medical News
Ora Appoints Industry Veteran Bill Sharbaugh as Chairman of the Board of Directors
BOSTON–(BUSINESS WIRE)– #ClinicalResearch–Leading global ophthalmic CRO Ora announces appointment of pharmaceutical industry veteran Bill Sharbaugh as Chairman of Board of Directors.
Sightview Expands Leadership Bench, Appointing Vice Presidents of Client Operations and Product Management
DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview, the only EHR and practice management partner focused solely on eyecare, has appointed Melissa Wright and Casi Nestleroad as VPs.
EyeDura's Sustained-Release Eye Drop Technology Wins Double Industry Honors
NEW YORK–(BUSINESS WIRE)–EyeDura Therapeutics Inc. (www.eyedura.com), a developer of preservative-free sustained release ophthalmic therapies, announced that it received top recognition at two major industry forums among a field of innovative ophthal…
Early Vitrectomy May Protect Vision in Post-Op Infections
Regardless of initial visual acuity, early vitrectomy can benefit patients who develop endophthalmitis after cataract surgery or intravitreal injection, a recent retrospective study shows. Medscape Medical News
Golden Age Health e Innostellar Biotherapeutics siglano un accordo di collaborazione esclusiva decennale per accelerare lo sviluppo della terapia genica LX-101 contro le distrofie retiniche ereditarie causate da mutazione del gene RPE65 in Cina
SHANGHAI–(BUSINESS WIRE)–Golden Age Health Pte. Ltd. (“GAH”) e Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) oggi hanno annunciato la sigla di un accordo esclusivo decennale riguardante servizi di promozione che concede a GAH i diritti esclus…
Golden Age Health e Innostellar Biotherapeutics assinam colaboração exclusiva de 10 anos para acelerar a terapia gênica LX-101 voltada a distrofias hereditárias de retina causadas por mutação no gene RPE 65 na China continental
XANGAI–(BUSINESS WIRE)–Golden Age Health Pte. Ltd. (“GAH”) e a Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) anunciaram hoje um Contrato de Serviços Promocionais exclusivo por dez anos que concede à GAH direitos exclusivos para comercializar …
Golden Age Health and Innostellar Biotherapeutics Sign Exclusive 10-Year Collaboration to Accelerate LX-101 Gene Therapy for Inherited Retinal Dystrophies due to RPE 65 gene mutation in Mainland China
SHANGHAI–(BUSINESS WIRE)–Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) today announced an exclusive ten-year Promotion Services Agreement that grants GAH sole rights to commercialise and promote Innoste…